Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxel.

<h4>Background</h4>The aim of the present study was to investigate the efficacy of adjuvant dose-dense sequential chemotherapy with epirubicin, paclitaxel, and CMF in subgroups of patients with high-risk operable breast cancer, according to tumor subtypes defined by immunohistochemistry (IHC).<h4>Ma...

Descrizione completa

Dettagli Bibliografici

Autori principali:	George Fountzilas, Urania Dafni, Mattheos Bobos, Anna Batistatou, Vassiliki Kotoula, Helen Trihia, Vassiliki Malamou-Mitsi, Spyros Miliaras, Sofia Chrisafi, Savvas Papadopoulos, Maria Sotiropoulou, Theodoros Filippidis, Helen Gogas, Triantafyllia Koletsa, Dimitrios Bafaloukos, Despina Televantou, Konstantine T Kalogeras, Dimitrios Pectasides, Dimosthenis V Skarlos, Angelos Koutras, Meletios A Dimopoulos
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Public Library of Science (PLoS) 2012-01-01
Serie:	PLoS ONE
Accesso online:	https://doi.org/10.1371/journal.pone.0037946
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!